abstract |
The present invention relates to a novel quinazoline derivative compound and uses thereof, and more particularly, to a novel quinazoline derivative compound of Formula 1 having inhibitory activity against Bromodomain Extra-Terminal (BET) protein and a BET protein comprising the same It relates to a pharmaceutical composition for the prevention or treatment of related diseases. |